Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of alpelisib in children and adults with PIK3CA-Related Overgrowth Spectrum (PROS)

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium France Germany Italy The Netherlands +1
  • Study of RLY-2608 for Adults and Children with PIK3CA-Related Overgrowth and Malformations

    Recruiting

    2 1 1
    Investigated Drugs:
    Belgium France Germany Ireland Italy Norway +1
  • Study on the Effects and Safety of Alpelisib for Children and Adults with Megalencephaly-Capillary Malformation Polymicrogyria Syndrome

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study of alpelisib in children and adults with PIK3CA-Related Overgrowth Spectrum (PROS)

    Not recruiting

    2 1
    Investigated Drugs:
    France Germany Italy The Netherlands Norway Spain
  • Study on the Long-Term Safety of Alpelisib for Patients with PIK3CA-Related Overgrowth Spectrum (PROS)

    Not recruiting

    2 1 1
    Investigated Drugs:
    France Ireland Spain
  • Long-term Safety Study of Miransertib for Patients with PIK3CA-related Overgrowth Spectrum or Proteus Syndrome

    Not recruiting

    2 1 1
    Investigated Drugs:
    Italy